Table 2

The median and interquartile ranges (IQR) for each muscle group and the significance between targeted and non-targeted sides (Wilcoxon signed ranks test p<0.05)

Targeted legNon-targeted leg
Muscle groupBefore median (IQR)After median (IQR)Median changep Value before/aft er changeBefore median (IQR)After median (IQR)Median changep Value before/aft er changep Value for difference in improvement between legs
Initial treatment group
    Flexor3 (2–3)0 (0–1)20.0013 (2–4)2 (1–3)10.0760.02
    Extensor3 (2–3)0 (0–1)20.0013 (2–3)2 (1–3)00.0160.01
    Dorsiflexor3 (1–3)0 (0–2)10.0033 (2–3)2 (0–3)20.010.02
Serial treatment group
    Flexor2 (2–3.25)0.5 (0–1)20.0062.5 (1.75–3)0 (0–1)20.0070.78
    Extensor2.5 (1.75–3)1 (0–1.25)1.50.0072.5 (1–3)0.5 (0–1)1.50.0070.52
    Dorsiflexor2.5 (0.75–3)0 (0–1)1.50.0162 (0.75–3)0.5 (0–1.25)10.0560.50